Type to search

Amniotics AB Announces Positive Pre-clinical Proof-of-concept Results for PulmoStem™ in End-stage Lung Disease | Pharmtech Focus
Amniotics Receives Approval for Phase I/II Study of Pulmostem™ in Hospitalized COVID-19 Patients | Pharmtech Focus
Amniotics Strengthens its Clinical and Regulatory Capabilities | Pharmtech Focus